Found: 6
Select item for more details and to access through your institution.
Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 7, p. 396, doi. 10.1002/gcc.22841
- By:
- Publication type:
- Article
DNA instability in low-risk myelodysplastic syndromes: refractory anemia with or without ring sideroblasts.
- Published in:
- Human Molecular Genetics, 2008, v. 17, n. 14, p. 2144, doi. 10.1093/hmg/ddn113
- By:
- Publication type:
- Article
High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 1, p. 27, doi. 10.1111/ejh.12457
- By:
- Publication type:
- Article
Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 2, p. 304, doi. 10.1046/j.1365-2141.1998.00551.x
- By:
- Publication type:
- Article
Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 1, p. 11, doi. 10.1007/s00277-012-1568-1
- By:
- Publication type:
- Article
První české zkušenosti s lenalidomidem v terapii anemických nemocných s myelodysplastickým syndromem s delecí dlouhého ramene 5. chromozomu.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2015, v. 61, n. 12, p. 1028
- By:
- Publication type:
- Article